Duodenal administered seal oil for patients with subjective food hypersensitivity: An explorative open pilot study

International Journal of General Medicine

Volumn 3, Issue , 2010, Pages 383-392

  Gregersen, Kine ^a,b   Lind, Ragna A ^a   Valeur, Jørgen ^a,c   Bjørkkjær, Tormod ^b   Berstad, Arnold ^a,c   Lied, Gülen Arslan Lied ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b INSTITUTE OF MARINE RESEARCH   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Food hypersensitivity; Irritable bowel syndrome; N 3 polyunsaturated fatty acids; Quality of life; Seal oil; Subjective health complaints

Indexed keywords

EDIBLE OIL; SEAL OIL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DUODENUM INTUBATION; FATIGUE; FEMALE; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL SYMPTOM RATING SCALE; GENERAL CONDITION IMPROVEMENT; HEADACHE; HUMAN; INDIGESTION; IRRITABLE COLON; MALE; MUSCULOSKELETAL PAIN; PILOT STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEAL; SHORT FORM OF THE NEPEAN DYSPEPSIA INDEX; SLEEP DISORDER; STOMACH PAIN; SUBJECTIVE HEALTH COMPLAINT; THERAPY EFFECT; ULCER ESOPHAGITIS SUBJECTIVE SYMPTOMS SCALE;

EID: 80052524804     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Jansen JJ, Kardinaal AFM, Huijbers G, Vlieg-Boerstra BJ, Martens BP, Ockhuizen T. Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol. 1994;93: 446-456.
2. Osterballe M, Hansen T, Mortz CG, Høst A, Bindslev-Jensen C. The prevalence of food hypersensitivity in an unselected population of children and adults. Pediatr Allergy Immunol. 2005;16:567-573.
3. Arslan G, Lind R, Olafsson S, Florvaag E, Berstad A. Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean dyspepsia index. Dig Dis Sci. 2004; 49:680-687.
4. Aziz Q. Visceral hypersensitivity: fact or fiction. Gastroenterology. 2006; 131:661-670.
5. Lind R, Arslan G, Eriksen HR, et al. Subjective health complaints and modern health worries in patients with subjective food hypersensitivity. Dig Dis Sci. 2005;50:1245-1251.
6. Ihlebaek C, Eriksen HR, Ursin H. Prevalence of subjective health complaints (SHC) in Norway. Scand J Public Health. 2002;30: 20-29.
7. Ursin H, Eriksen HR. Sensitization, subjective health complaints, and sustained arousal. Ann N Y Acad Sci. 2001;933:119-129.
8. Lillestøl K, Berstad A, Lind R, Florvaag E, Lied GA, Tangen T. Anxiety and depression in patients with self-reported food hypersensitivity. Gen Hosp Psychiatry. 2010;32:42-48.
9. Munk-Jorgensen P, Allgulander C, Dahl AA, et al. Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden. Psychiatr Serv. 2006;57:1738-1744.
10. Crayton JW. Adverse reactions to foods: relevance to psychiatric disorders. J Allergy Clin Immunol. 1986;78:243-250.
11. Lind R, Lied GA, Lillestøl K, Valeur J, Berstad A. Do psychological factors predict symptom severity in patients with subjective food hypersensitivity? Scand J Gastroenterol. 2010;45(7-8):835-843.
12. Gwee KA. Post-infectious irritable bowel syndrome, an inflammationimmunological model with relevance for other IBS and functional dyspepsia. J Neurogastroenterol Motil. 2010;16:30-34.
13. Cleland LG, James MJ, Proudman SM. Fish oil: what the prescriber needs to know. Arthritis Res Ther. 2006;8:202-210.
14. Chen C. COX-2's new role in inflammation. Nat Chem Biol. 2010; 6(6):401-402.
15. Clarke G, Fitzgerald P, Hennessy AA, et al. Marked elevations in proinflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J Lipid Res. 2010;51:1186-1192.
16. Brox J, Olaussen K, Østerud B, et al. A long-term seal- and cod-liveroil supplementation in hypercholesterolemic subjects. Lipids. 2001; 36:7-13.
17. Arslan G, Brunborg LA, Frøyland L, Brun JG, Valen M, Berstad A. Effects of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids. 2002;37:935-940.
18. Bjørkkjær T, Araujo P, Madland TM, Berstad A, Frøyland L. A randomized double blind comparison of short-term duodenally administrated whale and seal blubber oils in patients with inflammatory bowel disease and joint pain. Prostaglandins Leukot Essent Fatty Acids. 2009; 81:425-432.
19. Bjørkkjær T, Brunborg LA, Arslan G, et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand J Gastroenterol. 2004;39:1088-1094.
20. Gregersen K, Lind R, Bjørkkjær T, Frøyland L, Berstad A. Effects of seal oil on meal-induced symptoms and gastric accommodation in patients with subjective food hypersensitivity: a pilot study. Clin Med Gastroenterol. 2008;1:33-41.
21. Arslan G, Kahrs GE, Lind R, Frøyland L, Florvaag E, Berstad A. Patients with subjective food hypersensitivity: the value of analyzing intestinal permeability and inflammation markers in gut lavage fluid. Digestion. 2004;70:26-35.
22. Lie O, Lambertsen G. Fatty acid composition of glycerolphospholipids in seven tisues of cod (Gadus morhua), determined by combined high-performance liquid chromatography and gas chromatography. J Chromatogr. 1991;565:119-129.
23. Nöll GN. High-performance liquid chromatographic analysis of retinal and retinol isomers. J Chromatogr A. 1996;721:247-259.
24. Moren M, Opstad I, Hamre K. A comparison of retinol, retinal and retinyl ester concentrations in larvae of Atlantic halibut (Hippoglossus hippoglossus L.) fed Artemia or zooplankton. Aquac Nutr. 2004;10: 253-259.
25. CEN. Foodstuffs - determination of vitamin E by high performance liquid chromatograpy - measurement of aplha-, beta-, gamma-, and delta-tocopherols (prEN 12822). 2000.
26. Hamre K, Næss T, Espe M, Holm JC, Lie Ø. A formulated diet for Atlantic halibut (Hippoglossus hippoglossus, L.) larvae. Aquac Nutr. 2001;7:123-132.
27. Schmedes A, Hølmer G. A new thiobarbituric acid (TBARS) method for determining free malondialdehyde (MDA) and hydroperoxides selectively as a measure of lipid peroxidation. JAOCS. 1989;66:813-817.
28. Eriksen HR. A scoring system for subjective health complaints (SHC). Scand J Public Health. 1999;27:63-72.
29. Olafsson S, Hatlebakk JG, Berstad A. Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers. Scand J Gastroenterol. 2002;37:1386-1394.
30. Dimenäs E, Glise H, Hallerbäck H, Hernqvist J, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol. 1993;28:681-687.
31. NRRK: http://www.nrrk.no/modules/module_123/proxy. asp?Dequals;2&Cequals;634&Iequals;2668
32. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean dyspepsia index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001;15:207-216.
33. Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7:48-53.
34. Bjørkkjær T, Brun JG, Valen M, et al. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids Health Dis. 2006;5:6.
35. Madland TM, Bjørkkjær T, Brunborg LA, Frøyland L, Berstad A, Brun JG. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil. J Rheumatol. 2006;33:307-310.
36. Brunborg LA, Madland TM, Lind RA, Arslan G, Berstad A, Frøyland L. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil. Clin Nutr. 2008;27:614-622.
37. Öhman L, Lindmark AC, Isaksson S, et al. B-cell activation in patients with irritable bowel syndrome (IBS). J Neurogastroenterol Motil. 2009;21:644-650.
38. Kindt S, van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. J Neurogastroenterol Motil. 2009;21:389-398.
39. Arslan G, Ødegaard S, Elsayed S, Florvaag E, Berstad A. Food allergy and intolerance: response to intestinal provocation monitored by endosonography. Eur J Ultrasound. 2002;15:29-36.
40. Stulnig TM. Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol. 2003;132:310-321.
41. Simopoulos AP. The role of fatty acids in gene expression: health implications. Ann Nutr Metab. 1996;40:303-311.
42. Robinson DR, Urakaze M, Huang R, et al. Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription. Lipids. 1996;31:S23-S31.
43. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med. 2005;202: 1023-1029.
44. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003-2014.
45. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979-1988.
46. Valeur J, Morken MH, Norin E, Midtvedt T, Berstad A. Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose. Scand J Gastroenterol. 2009; 44:1416-1423.
47. Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 2008;6:765-771.
48. Thompson L, Spiller RC. Impact of polyunsaturated fatty acids on human colonic bacterial metabolism: an in vitro and in vivo study. Br J Nutr. 1995;74:733-741.
49. Benninga MA, Mayer EA. The power of placebo in pediatric functional gastrointestinal disease. Gastroenterology. 2009;137:1207-1210.